A Phase 2 B, Multicenter, 30 week, Prospective, Cross over, Double blind, Randomized, Placebo controlled Study Followed by a 52 Week Open label Extension Study to Evaluate the Efficacy and Safety of Basimglurant Adjunctive to Ongoing Anticonvulsive Therapy in Children, Adolescents, and Young Adults with Seizures Associated with Tuberous Sclerosis Complex | AVESİS

Manisa Celal Bayar Üniversitesi Akademik Veri Yönetim Sistemi

A Phase 2 B, Multicenter, 30 week, Prospective, Cross over, Double blind, Randomized, Placebo controlled Study Followed by a 52 Week Open label Extension Study to Evaluate the Efficacy and Safety of Basimglurant Adjunctive to Ongoing Anticonvulsive Therapy in Children, Adolescents, and Young Adults with Seizures Associated with Tuberous Sclerosis Complex

AYÇA S., ÇOKAR A. Ö.

Diğer Uluslararası Fon Programları, 2023 - 2024

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Şubat 2023
Bitiş Tarihi: Aralık 2024